NSE · Healthcare · Drug Manufacturers - Specialty & Generic
| Document | Date |
|---|---|
| Annual report FY2026 | 2026-08-14 |
| Q1 FY27 earnings call ANLON HEALTHCARE LIMITED – Q1 FY27 EARNINGS SUMMARY HEADLINE NUMBERS • Q1 FY27 consolidated total income: ₹87.62 crore vs ₹33.31 crore in Q1 FY26 (1 | 2026-08-12 |
| Investor presentation ANLON HEALTHCARE LIMITED – INVESTOR SUMMARY --- HEADLINE NUMBERS • FY26 Revenue: ₹171.97 crore (up 43% YoY from ₹120.29 crore in FY25) • FY26 EBITD | 2026-08-05 |
| Quarterly results · Q4 FY26 ANLON HEALTHCARE LIMITED – FINANCIAL SUMMARY Q1 FY2025-26 (Quarter Ended June 30, 2025) --- HEADLINE NUMBERS • Revenue from Operations (Q1): Rs 3,3 | 2026-06-25 |
| Q4 FY26 earnings call ANLON HEALTHCARE LIMITED – Q4 & FY26 EARNINGS SUMMARY HEADLINE NUMBERS • FY26 Total Income: INR 172.22 crore, up 42.98% YoY from INR 120.46 crore in | 2026-06-09 |
| Investor presentation · Q4 FY26 ANLON HEALTHCARE LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • FY26 Revenue: ₹171.97 crore (up 42.9% YoY from ₹120.29 crore in FY25) • FY26 EBITDA: | 2026-06-03 |
| Q3 FY26 earnings call ANLON HEALTHCARE LIMITED – Q3/9M FY26 SUMMARY HEADLINE NUMBERS • Q3 FY26 Total Income: 35.78 crore vs 9.38 crore in Q3 FY25 (282% YoY growth) • Q3 F | 2026-02-24 |
| Investor presentation ANLON HEALTHCARE LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • Q3 FY26 Revenue: ₹35.58 crore (vs. ₹9.36 crore in Q3 FY25) – 280% YoY growth • 9M FY2 | 2026-02-19 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Split | ₹10 → ₹2 ex-date Apr 24, 2026 | 2026-04-24 |
| Bonus issue | 1 : 1 ex-date Apr 24, 2026 | 2026-04-24 |
| Announcement | Date |
|---|---|
| Acquisition of stake in Remember India Health Links Private Limited Anlon Healthcare Limited has successfully completed the acquisition of a 63.98% majority stake in Remember India Health Links Private Limited on May 8, 2026. This acquisition was previously | 2026-05-08 |
| Acquisition of stake in Bizotic Life Science Private Limited Anlon Healthcare Limited has successfully completed the acquisition of a 56.67% equity stake in Bizotic Life Science Private Limited (a private company) on March 20, 2026. This makes Bizotic | 2026-03-20 |
| Amendment in share purchase agreement for stake acquisition in another business Anlon Healthcare Limited announced an amendment to its previously disclosed Share Purchase Agreement (SPA) dated November 28, 2025, regarding the acquisition of a 56.67% stake in Bizotic Lif | 2026-02-27 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Anlon Healthcare Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.